Neurophysiological consequences of acute exposure to methylpyridines.
A series of neurophysiological tests was performed on Long-Evans hooded rats treated with either 2-, 3-, or 4-methylpyridine at dosages of 100 mg/kg, approximately one-half the ip LD50. The tests contained measures of sensory function (paired pulse flash evoked potentials, pattern reversal evoked potentials, and brainstem auditory evoked responses) and cerebral excitability (pentylenetetrazol seizures and hippocampal afterdischarges). In general, rats treated with 2- and 3-methylpyridine were more affected than those treated with 4-methylpyridine. The changes observed were in many ways similar to those seen following administration of depressant compounds: increased latency of evoked potentials and increased latency to PTZ seizures. Not all findings, however, were consistent with previously observed patterns of central nervous system depression.
D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D005072:Evoked Potentials, Auditory / Q000187:drug effects*; D005074:Evoked Potentials, Visual / Q000187:drug effects*; D005260:Female; D007928:Lethal Dose 50; D008297:Male; D010433:Pentylenetetrazole; D011725:Pyridines / Q000633:toxicity*; D051381:Rats; D012640:Seizures / Q000139:chemically induced
D011725:Pyridines; D010433:Pentylenetetrazole